2BH Stock Chart & Stats
CHF328.66
CHF0.00(0.00%)
At close: 4:00 PM EDT
CHF328.66
CHF0.00(0.00%)
Day’s Range― - ―
52-Week RangeCHF292.71 - CHF364.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
CHF78.49B
Enterprise ValueCHF140.73K
Total Cash (Recent Filing)CHF1.01B
Total Debt (Recent Filing)CHF48.78B
Price to Earnings (P/E)14.4
Beta0.73
Next Earnings
Oct 23, 2026EPS Estimate
5.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)29.96
Shares Outstanding216,501,500
10 Day Avg. Volume1
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.57
Price to Book (P/B)-17.87
Price to Sales (P/S)1.42
P/FCF Ratio14.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF376.62Price Target Upside14.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering22
EPS Forecast (FY)24.53
Revenue Forecast (FY)CHF65.35B
Bulls Say, Bears Say
Bulls Say
Large-scale Profitable Healthcare NetworkHCA’s substantial hospital and outpatient network supports meaningful scale, healthy operating profitability, and broad service coverage. This earnings base can fund continued investment, reinforce its market position, and provide resilience as patient volumes and care settings evolve over the next several quarters.
Resilient Demand And Expanding Outpatient FootprintGrowing admissions and emergency volumes indicate ongoing demand for HCA’s services, while the addition of sites broadens access and referral reach. Its outpatient pipeline and expanding care network can support durable volume growth and complement the company’s hospital operations.
Meaningful Operating Cash Generation And Cost DisciplineHCA continues to convert operations into substantial cash while controlling cost per equivalent admission. This combination supports capital investment, network expansion, and shareholder returns, and gives management resources to pursue efficiency programs across hospitals and outpatient facilities.
Bears Say
High Leverage And Negative EquityHigh debt alongside negative equity leaves HCA with a limited traditional capital cushion and increases financial risk during operating weakness. Leverage can constrain flexibility for investment or acquisitions, while interest and refinancing obligations make sustained cash generation especially important.
Structural Payer-mix Pressure From Exchange Coverage LossesThe shift from exchange coverage to uninsured patients directly reduces reimbursement quality and is large enough to affect full-year profitability. Because the impact reflects coverage and policy changes, it can remain a material headwind for several quarters rather than a temporary volume fluctuation.
Margin Compression And Elevated Operating CostsLower net margins indicate that rising costs or unfavorable service and payer mix have reduced the amount of revenue retained as profit. Continued professional-fee pressure, including anesthesia and radiology costs, could limit operating leverage and make earnings growth less durable.
2BH FAQ
What was HCA Healthcare’s price range in the past 12 months?
HCA Healthcare lowest stock price was CHF292.71 and its highest was CHF364.40 in the past 12 months.
What is HCA Healthcare’s market cap?
HCA Healthcare’s market cap is CHF78.49B.
When is HCA Healthcare’s upcoming earnings report date?
HCA Healthcare’s upcoming earnings report date is Oct 23, 2026 which is in 23 days.
How were HCA Healthcare’s earnings last quarter?
HCA Healthcare released its earnings results on Jul 24, 2026. The company reported CHF6.294 earnings per share for the quarter, beating the consensus estimate of CHF6.271 by CHF0.023.
Is HCA Healthcare overvalued?
According to Wall Street analysts HCA Healthcare’s price is currently Undervalued.
Does HCA Healthcare pay dividends?
HCA Healthcare does not currently pay dividends.
What is HCA Healthcare’s EPS estimate?
HCA Healthcare’s EPS estimate is 5.54.
How many shares outstanding does HCA Healthcare have?
HCA Healthcare has 216,501,500 shares outstanding.
What happened to HCA Healthcare’s price movement after its last earnings report?
HCA Healthcare reported an EPS of CHF6.294 in its last earnings report, beating expectations of CHF6.271. Following the earnings report the stock price went up 10.442%.
Which hedge fund is a major shareholder of HCA Healthcare?
Currently, no hedge funds are holding shares in CH:2BH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HCA Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF376.62 (14.59% Upside)
CHF376.62 (14.59% Upside)
Blogger Sentiment
Bullish
CH:2BH Sentiment 82%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.93%
12-Months-Change
Fundamentals
Return on Equity
0.71%
Trailing 12-Months
Asset Growth
6.24%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HCA Healthcare
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
2BH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: operational demand and underlying profitability showed resilience (11% EPS growth, volume increases outside the exchanges, meaningful Medicaid supplemental payments, ongoing capital deployment and share repurchases). However, a large, concentrated payer-mix shock from the expiration of enhanced premium tax credits (exchange enrollment down ~15% and near 1-for-1 migration to uninsured) created a significant adjusted EBITDA headwind (~$400M in Q2 and an estimated $1.0B–$1.2B full-year impact), contributed to lower cash flow this quarter, and pressured elective surgical volumes. Management has responded by updating guidance (now aligned with long-term adjusted EBITDA growth of 4%–6%), advancing cost resiliency programs, and preserving capital allocation priorities. Overall, positives (profitability, cost discipline, supplemental payment benefits, and network expansion) are balanced against material policy-driven revenue and payer-mix challenges.View all CH:2BH earnings summaries2BH Revenue Breakdown
28.15% National Group
32.68% Atlantic Group
34.98% American Group
4.19% Corporate and other

2BH Stock 12 Month Forecast
Average Price Target
CHF376.62
▲(14.59% Upside)
Technical Analysis
Community Health
―
Encompass Health
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―











